Market Tracker

10/31 6:34pm ET

Taro Pharmaceutical Industries Ltd (NYSE:TARO)

161.93
Data as of 2:55pm ET
 +4.23 / +2.68%
Today’s Change
76.40
Today|||52-Week Range
165.30
+63.73%
Year-to-Date
No recent news for Taro Pharmaceutical Industries Ltd.

Today’s Trading

Previous close157.70
Today’s open159.95
Day’s range157.98 - 162.75
Volume187,705
Average volume (3 months)112,191
Market cap$6.8B
Dividend yield--
Data as of 2:55pm ET, 10/31/2014

Growth & Valuation

Earnings growth (last year)+36.58%
Earnings growth (this year)+30.06%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+13.16%
P/E ratio--
Price/Sales6.47
Price/Book6.65

Competitors

 Today’s
change
Today’s
% change
IDXXIDEXX Laboratories I...-1.19-0.83%
UTHRUnited Therapeutics ...+0.10+0.08%
PBYIPuma Biotechnology I...+2.88+1.16%
ALKSAlkermes Plc-0.70-1.36%
Data as of 3:17pm ET, 10/31/2014

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$759.3M
Annual profit (last year)$360.4M
Net profit margin47.51%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Director
Kal Sundaram
Chief Financial &
Accounting Officer, Group VP
Michael Kalb
Corporate headquarters
Haifa Bay, --

Forecasts